Ginkgolic acids can reduce pulmonary fibrosis both in vitro and in mouse models through the inhibition of the TGF-b1-mediated SUMOylation of SMAD4 and epithelial–mesenchymal transition [58]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.